IBEC’s newest group leader will advance drug delivery systems
IBEC gains a new group leader this month, with Prof. Silvia Muro joining the institute as an ICREA research professor to lead her Targeted Therapeutics and Nanodevices group.
In her new position, she will carry out research into macromolecular nano-assemblies which can be loaded with drugs to target the chronic conditions that affect our pediatric and ageing populations, such as neurodegenerative, cardiovascular or metabolic diseases, as well as cancer.
Prof. Muro spent the last nine years at the University of Maryland, first as an Assistant Professor and then as a tenured Associate Professor with a joint appointment in the Fischell Department of Bioengineering and the Institute for Bioscience and Biotechnology Research.
Yesterday and today IBEC has been exhibiting at the Coventry Life Festival in the UK, a celebration of active ageing which is taking place in the university town not far from Birmingham.